Although the conclusion is based only on 9 studies in total, the results suggest that dupilumab may have a role in the treatment of eosinophilic asthma and should be compared to mepolizumab, reslizumab, and benralizumab in a direct, RCT
Although the conclusion is based only on 9 studies in total, the results suggest that dupilumab may have a role in the treatment of eosinophilic asthma...